These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 368005)

  • 41. [Susceptibility of recent clinical isolates of Pseudomonas aeruginosa and Serratia marcescens to cefotaxime, ceftizoxime, cefmenoxime, latamoxef and cefsulodin in comparison with other beta-lactam antibiotics and aminoglycosides].
    Kawakami Y; Okimura Y; Horiuchi N; Kanai M
    Jpn J Antibiot; 1982 Sep; 35(9):2314-7. PubMed ID: 6292543
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical studies on urinary tract infections caused by Serratia marcescens. I. Clinical and bacteriological studies on urinary tract infections caused by Serratia marcescens].
    Sakai S; Kumamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1983 Apr; 74(4):467-84. PubMed ID: 6353020
    [No Abstract]   [Full Text] [Related]  

  • 43. Reversion to bacillary forms of Serratia marcescens spheroplasts induced by carbenicillin. Scanning electron microscopic study.
    Furutani A; Tada Y; Yamaguchi J
    Microbiol Immunol; 1985; 29(10):901-7. PubMed ID: 3908886
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Combined effects of micronomicin and latamoxefi in vitro synergistic activities].
    Kurimoto T; Okachi R
    Jpn J Antibiot; 1983 Jul; 36(7):1599-603. PubMed ID: 6418932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The in vitro effect of gentamicin-carbenicillin association on the Serratia group].
    Denis F; Brisou J
    Arch Roum Pathol Exp Microbiol; 1971 Jun; 30(2):209-16. PubMed ID: 5211725
    [No Abstract]   [Full Text] [Related]  

  • 46. Serratia marcescens infections--selection of an antibiotic.
    Ball AP
    J Antimicrob Chemother; 1976 Dec; 2(4):317-9. PubMed ID: 802122
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of subinhibitory levels of aminoglycosides and fluoroquinolines on hydrophobicity and motility of Serratia marcescens].
    Majtán V; Majtánová L
    Epidemiol Mikrobiol Imunol; 2001 Feb; 50(1):26-30. PubMed ID: 11233670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activity of cefsulodin, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa.
    Chandrasekar PH; Schell RF; LeFrock JL; Rolston KV; Francisco M
    Chemotherapy; 1984; 30(3):165-9. PubMed ID: 6428812
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug resistance, R plasmids and pigmentation of Serratia marcescens isolated in Taiwan.
    Ding MJ; Sung SJ
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):69-79. PubMed ID: 3297535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A laboratory assessment of the activities of four aminoglycosides.
    Schrire L; Robinson RG; Koornhof HJ
    S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro activity of tobramycin and gentamicin against Enterobacteriaceae and gentamicin-resistant, carbenicillin-resistant Pseudomonas aeruginosa.
    Watanakunakorn C; Bannister T
    Curr Ther Res Clin Exp; 1975 May; 17(5):488-96. PubMed ID: 805033
    [No Abstract]   [Full Text] [Related]  

  • 52. Antimicrobial susceptibility of Serratia marcescens isolated from clinical materials.
    Igari J; Oguri T; Kosakai N
    Jpn J Antibiot; 1984 Sep; 37(9):1625-30. PubMed ID: 6392599
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serratia marcescens isolated in 2005 from clinical specimens from patients with diminished immunity.
    Młynarczyk A; Młynarczyk G; Pupek J; Bilewska A; Kawecki D; Łuczak M; Gozdowska J; Durlik M; Paczek L; Chmura A; Rowińnski W
    Transplant Proc; 2007 Nov; 39(9):2879-82. PubMed ID: 18022007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Behavior of hospital Serratia in the presence of several antibiotic associations].
    Brisou J; Denis F
    Pathol Biol (Paris); 1971; 19(11):655-60. PubMed ID: 4933629
    [No Abstract]   [Full Text] [Related]  

  • 55. Sensitivity of Serratia to tetracycline.
    Siboni K
    Acta Pathol Microbiol Scand B; 1980 Aug; 88(4):189-92. PubMed ID: 6998255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on the combined action of antibiotics on Pseudomonas aeruginosa strains.
    Muszyński Z; Kedzia W
    Arch Immunol Ther Exp (Warsz); 1973; 21(5):743-51. PubMed ID: 4358926
    [No Abstract]   [Full Text] [Related]  

  • 57. State of penicillin-binding proteins and requirements for their bactericidal interaction with beta-lactam antibiotics in Serratia marcescens highly resistant to extended-spectrum beta-lactams.
    Gunkel AG; Hechler U; Martin HH
    J Gen Microbiol; 1991 Feb; 137(2):243-52. PubMed ID: 2016583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surveillance of antimicrobial resistance in Serratia marcescens in Mexico.
    González GM; de J Treviño-Rangel R; Campos CL; Villanueva-Lozano H; Bonifaz A; Franco-Cendejas R; López-Jácome LE; Bobadilla Del Valle M; Llaca-Díaz JM; Ayala-Gaytán JJ; Castañón-Olivares LR; Tinoco JC; Andrade A
    New Microbiol; 2020 Jan; 43(1):34-37. PubMed ID: 32334489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antibiotic associations on acting Pseudomonas aeruginosa].
    Duval J; Mathieu-Saint-Laurent P; Soussy CL
    Pathol Biol (Paris); 1971; 19(11):637-48. PubMed ID: 4997792
    [No Abstract]   [Full Text] [Related]  

  • 60. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens.
    Ullmann U; Lindemann B
    Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.